An HIV drug could stop one of the early changes in skin cancer cells that leads to them becoming resistant to treatment, according to a Cancer Research UK-funded study published in Cancer Cell today ...

While older patients with HIV had a higher risk for cutaneous malignancies than younger adults with HIV, both groups had significantly higher risks for oncovirus infections when compared with control ...

Sometimes in life science, simple research strategies often provide the basis for new therapeutic approaches. For HIV, the development of safe and effective vaccines has proven to be challenging.

The patient is a 32-year-old man with HIV diagnosed in 1995 after presenting with cryptococcal meningitis. The patient recovered from the meningitis and was prescribed secondary prophylaxis with ...

This illustration shows how the HIV virus slips between loosely connected skin cells to reach its immune cell targets such as the Langerhans cells (orange), macrophages (purple), dendritic cells ...

People with human immunodeficiency virus (HIV) are living longer thanks to treatments like antiretroviral therapy, or ART. That’s a medication that lowers the amount of HIV in your body and keeps your ...